Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.
Bagga
R
R
Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh-160012, India. drbagga@glide.net.in
Chaudhary
N
N
Kalra
J
J
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000028:Abortion, Induced / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D016595:Misoprostol / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone